Apogee Therapeutics, Inc. (APGE)
82.72
-2.28
(-2.68%)
USD |
NASDAQ |
Jun 10, 16:00
83.04
+0.32
(+0.39%)
Pre-Market: 08:14
Apogee Therapeutics Price : 82.72 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 84.88 | 87.43 | 81.59 | 82.72 | 789054.0 |
| Jun 09, 2026 | 83.68 | 85.37 | 81.04 | 85.00 | 643806.0 |
| Jun 08, 2026 | 87.35 | 88.70 | 82.14 | 83.01 | 1.317M |
| Jun 05, 2026 | 90.00 | 91.90 | 85.75 | 86.92 | 1.308M |
| Jun 04, 2026 | 84.00 | 91.80 | 84.00 | 90.90 | 1.471M |
| Jun 03, 2026 | 78.71 | 85.18 | 78.71 | 84.19 | 1.129M |
| Jun 02, 2026 | 77.10 | 80.24 | 77.10 | 78.71 | 1.114M |
| Jun 01, 2026 | 80.12 | 81.99 | 78.81 | 79.30 | 806702.0 |
| May 29, 2026 | 78.22 | 82.49 | 77.00 | 82.14 | 1.417M |
| May 28, 2026 | 77.87 | 79.43 | 77.11 | 77.82 | 1.244M |
| May 27, 2026 | 78.00 | 85.99 | 75.86 | 77.75 | 4.032M |
| May 26, 2026 | 82.24 | 84.66 | 81.08 | 82.81 | 443886.0 |
| May 22, 2026 | 82.43 | 84.12 | 81.03 | 81.16 | 338435.0 |
| May 21, 2026 | 80.41 | 83.24 | 75.00 | 82.43 | 369947.0 |
| May 20, 2026 | 79.40 | 82.29 | 79.00 | 81.39 | 766783.0 |
| May 19, 2026 | 78.45 | 78.98 | 75.77 | 78.27 | 976488.0 |
| May 18, 2026 | 81.46 | 82.00 | 78.33 | 78.75 | 748131.0 |
| May 15, 2026 | 82.89 | 84.44 | 77.85 | 81.14 | 714815.0 |
| May 14, 2026 | 83.94 | 85.32 | 81.57 | 83.91 | 631392.0 |
| May 13, 2026 | 82.47 | 84.62 | 81.46 | 83.94 | 745805.0 |
| May 12, 2026 | 82.19 | 85.17 | 81.48 | 82.93 | 497173.0 |
| May 11, 2026 | 83.99 | 88.28 | 83.33 | 84.60 | 983941.0 |
| May 08, 2026 | 82.76 | 84.15 | 82.06 | 83.03 | 768713.0 |
| May 07, 2026 | 84.38 | 85.02 | 80.83 | 81.81 | 376713.0 |
| May 06, 2026 | 83.88 | 85.03 | 83.38 | 84.54 | 413676.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evommune, Inc. | 20.49 |
| Cogent Biosciences, Inc. | 31.38 |
| Kymera Therapeutics, Inc. | 78.23 |
| Erasca, Inc. | 13.37 |
| GRAIL, Inc. | 58.59 |
Price Related Metrics
| PEG Ratio | -0.8622 |
| Price to Book Value | 4.933 |
| Earnings Yield | -5.23% |
| Market Cap | 6.194B |
| PEGY Ratio | -0.8622 |